myTomorrows provides physicians and patients that are excluded from clinical trials access to innovative drugs in development. The Company focuses on disease areas with high unmet needs; oncology, neurology, psychiatry and rare diseases. myTomorrows identifies innovative drugs, informs physicians and patients and facilitates requests for access to these drugs in development.